AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtoss 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Astonea Labs Private Limited

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimtoss 0.5mg/500mg Tablet

Diabetol Duo 0.5mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetol Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifested by sweating, dizziness, headache, and tremors. Carry a fast-acting glucose source (e.g., sugary snacks or juice) to counter this. Alcohol consumption should be minimized due to its hypoglycemic risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Diabetol Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests for blood cell counts and liver function, are recommended.

Uses of Glimtoss 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimtoss 0.5mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Glimtoss 0.5mg/500mg tablets with a meal.

Common Side effects of Glimtoss 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtoss 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimtoss 0.5mg/500mg Tablet whole; do not break, crush, or chew it. Administer this medication with food.

How Glimtoss 0.5mg/500mg Tablet works:

Each Glimtoss 0.5mg/500mg tablet unites glimepiride (a sulfonylurea) and metformin (a biguanide), two antidiabetic agents. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin's action is threefold: it decreases hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimtoss 0.5mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimtoss 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glimtoss 0.5mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimtoss 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimtoss 0.5mg/500mg tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimtoss 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, Glimtoss 0.5mg/500mg tablets should begin at a low dose; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimtoss 0.5mg/500mg Tablet :

Should you forget to take your Glimtoss 0.5mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtoss 0.5mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimtoss 0.5mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medicine. Prevent access by children, pets, and others.
Glimtoss 0.5mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction poses a significant risk to individuals with impaired kidney function, the elderly, and heavy alcohol consumers. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Glimtoss 0.5mg/500mg Tablet use and seek immediate medical attention.
Glimepiride/Metformin 0.5mg/500mg tablets (e.g., Glimtoss) combine two antidiabetic agents to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when coupled with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Glimtoss 0.5mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal discomfort, loose stools, and headache. Rare but potentially serious adverse reactions include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimtoss 0.5mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency by impairing its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as numbness and tingling in extremities), weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include annual supplemental Vitamin B12 intake.
Glimtoss 0.5mg/500mg Tablets may induce hypoglycemia (low blood sugar). Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors may occur. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimtoss 0.5mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimtoss 0.5mg/500mg Tabl...
40
MRP 49
18% off